Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome
Language English Country England, Great Britain Media print
Document type Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
PubMed
29452342
DOI
10.1093/brain/awy021
PII: 4858419
Knihovny.cz E-resources
- MeSH
- Biomarkers cerebrospinal fluid MeSH
- Demyelinating Diseases cerebrospinal fluid diagnosis MeSH
- Adult MeSH
- Cohort Studies MeSH
- Middle Aged MeSH
- Humans MeSH
- Statistics, Nonparametric MeSH
- Neurofilament Proteins cerebrospinal fluid MeSH
- Oligoclonal Bands cerebrospinal fluid MeSH
- Prognosis MeSH
- Chitinase-3-Like Protein 1 cerebrospinal fluid MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Europe MeSH
- Names of Substances
- Biomarkers MeSH
- neurofilament protein L MeSH Browser
- Neurofilament Proteins MeSH
- Oligoclonal Bands MeSH
- Chitinase-3-Like Protein 1 MeSH
The prognostic role of cerebrospinal fluid molecular biomarkers determined in early pathogenic stages of multiple sclerosis has yet to be defined. In the present study, we aimed to investigate the prognostic value of chitinase 3 like 1 (CHI3L1), neurofilament light chain, and oligoclonal bands for conversion to clinically isolated syndrome and to multiple sclerosis in 75 patients with radiologically isolated syndrome. Cerebrospinal fluid levels of CHI3L1 and neurofilament light chain were measured by enzyme-linked immunosorbent assay. Uni- and multivariable Cox regression models including as covariates age at diagnosis of radiologically isolated syndrome, number of brain lesions, sex and treatment were used to investigate associations between cerebrospinal fluid CHI3L1 and neurofilament light chain levels and time to conversion to clinically isolated syndrome and multiple sclerosis. Neurofilament light chain levels and oligoclonal bands were independent risk factors for the development of clinically isolated syndrome (hazard ratio = 1.02, P = 0.019, and hazard ratio = 14.7, P = 0.012, respectively) and multiple sclerosis (hazard ratio = 1.03, P = 0.003, and hazard ratio = 8.9, P = 0.046, respectively). The best cut-off to classify cerebrospinal fluid neurofilament light chain levels into high and low was 619 ng/l, and high neurofilament light chain levels were associated with a trend to shorter time to clinically isolated syndrome (P = 0.079) and significant shorter time to multiple sclerosis (P = 0.017). Similarly, patients with radiologically isolated syndrome presenting positive oligoclonal bands converted faster to clinically isolated syndrome and multiple sclerosis (P = 0.005 and P = 0.008, respectively). The effects of high neurofilament light chain levels shortening time to clinically isolated syndrome and multiple sclerosis were more pronounced in radiologically isolated syndrome patients with ≥37 years compared to younger patients. Cerebrospinal fluid CHI3L1 levels did not influence conversion to clinically isolated syndrome and multiple sclerosis in radiologically isolated syndrome patients. Overall, these findings suggest that cerebrospinal neurofilament light chain levels and oligoclonal bands are independent predictors of clinical conversion in patients with radiologically isolated syndrome. The association with a faster development of multiple sclerosis reinforces the importance of cerebrospinal fluid analysis in patients with radiologically isolated syndrome.
1st Pavlov Saint Petersburg State Medical University Saint Petersburg Russia
Department of Neurology Charles University Prague 1st Faculty of Medicine Prague Czech Republic
Department of Neurology Medical University of Lublin Lublin Poland
Department of Neurology Neuroimmunological Section University of Rostock Rostock Germany
Genetics Microbiology and Statistics Department Universitat de Barcelona Barcelona Spain
Medical University of Innsbruck Department of Neurology Innsbruck Austria
MS Center Saint Petersburg Russia
Neuroimmunology Unit Hospital Universitario Puerta de Hierro Madrid Spain
Neurology Clinic Clinical Centre of Serbia Belgrade Serbia
University of Milan Fondazione Ca' Granda IRCCS Ospedale Policlinico Milan Italy
References provided by Crossref.org
The potential of serum neurofilament as biomarker for multiple sclerosis